$1.38 Billion is the total value of Ikarian Capital, LLC's 174 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 86.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRput | $94,716,000 | +238.4% | 850,000 | +240.0% | 6.85% | +207.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INCput | $91,161,000 | +432.3% | 549,000 | +266.0% | 6.60% | +384.0% |
| MRNA | Buy | MODERNA INCput | $77,394,000 | +301.8% | 1,093,900 | +264.6% | 5.60% | +265.4% |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $74,441,000 | – | 530,100 | +100.0% | 5.39% | – |
| SPY | Sell | SPDR S&P 500 ETF TRput | $66,977,000 | -69.0% | 200,000 | -71.4% | 4.85% | -71.8% |
| NVAX | New | NOVAVAX INCput | $40,675,000 | – | 375,400 | +100.0% | 2.94% | – |
| BIIB | New | BIOGEN INCput | $39,375,000 | – | 138,800 | +100.0% | 2.85% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB Lcall | $30,023,000 | – | 386,500 | +100.0% | 2.17% | – |
| BIIB | New | BIOGEN INCcall | $28,368,000 | – | 100,000 | +100.0% | 2.05% | – |
| CYTK | New | CYTOKINETICS INCcall | $25,364,000 | – | 1,171,600 | +100.0% | 1.84% | – |
| ZYME | Sell | ZYMEWORKS INCcall | $23,290,000 | -7.8% | 500,000 | -28.6% | 1.68% | -16.1% |
| IGMS | New | IGM BIOSCIENCES INCput | $23,124,000 | – | 313,300 | +100.0% | 1.67% | – |
| ASND | ASCENDIS PHARMA A/Scall | $22,376,000 | +4.3% | 145,000 | 0.0% | 1.62% | -5.2% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $21,796,000 | +1.8% | 1,469,730 | -10.8% | 1.58% | -7.5% |
| MCRB | Buy | SERES THERAPEUTICS INCcall | $21,585,000 | +1713.9% | 762,400 | +205.0% | 1.56% | +1544.2% |
| BCLI | New | BRAINSTORM CELL THERAPEUTICSput | $19,797,000 | – | 1,170,100 | +100.0% | 1.43% | – |
| ARNA | New | ARENA PHARMACEUTICALS INCcall | $19,446,000 | – | 260,000 | +100.0% | 1.41% | – |
| IGMS | New | IGM BIOSCIENCES INCcall | $18,452,000 | – | 250,000 | +100.0% | 1.34% | – |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $18,087,000 | – | 300,000 | +100.0% | 1.31% | – |
| ZGNX | Buy | ZOGENIX INCcall | $16,137,000 | +386.9% | 900,000 | +633.5% | 1.17% | +342.4% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $15,554,000 | +15.5% | 1,235,471 | +11.0% | 1.13% | +5.0% |
| KOD | New | KODIAK SCIENCES INCput | $14,802,000 | – | 250,000 | +100.0% | 1.07% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INCcall | $14,407,000 | +3354.9% | 102,600 | +3846.2% | 1.04% | +3060.6% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INCcall | $13,642,000 | +42.2% | 114,900 | +35.7% | 0.99% | +29.4% |
| INCY | INCYTE CORPcall | $13,461,000 | -13.7% | 150,000 | 0.0% | 0.97% | -21.5% | |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $13,061,000 | -23.7% | 1,716,293 | -16.5% | 0.94% | -30.7% |
| CYRX | New | CRYOPORT INCcall | $12,935,000 | – | 272,900 | +100.0% | 0.94% | – |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $12,764,000 | – | 1,743,545 | +100.0% | 0.92% | – |
| TARA | Buy | PROTARA THERAPEUTICS INC | $12,158,000 | -21.5% | 722,443 | +36.8% | 0.88% | -28.6% |
| CYRX | New | CRYOPORT INCput | $11,850,000 | – | 250,000 | +100.0% | 0.86% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCcall | $11,408,000 | -56.2% | 117,100 | -29.9% | 0.83% | -60.2% |
| ZYME | Buy | ZYMEWORKS INCput | $11,414,000 | +48.7% | 245,000 | +15.1% | 0.83% | +35.2% |
| IMVT | Buy | IMMUNOVANT INC | $11,328,000 | +64.9% | 321,887 | +14.1% | 0.82% | +49.9% |
| AIMT | New | AIMMUNE THERAPEUTICS INCput | $11,248,000 | – | 326,500 | +100.0% | 0.81% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $11,180,000 | – | 2,162,549 | +100.0% | 0.81% | – |
| SCPH | Buy | SCPHARMACEUTICALS INC | $11,033,000 | +2.1% | 1,481,147 | +0.9% | 0.80% | -7.2% |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $10,851,000 | +45.0% | 358,941 | +102.2% | 0.78% | +31.7% |
| MPW | MEDICAL PPTYS TRUST INCput | $10,579,000 | -6.2% | 600,000 | 0.0% | 0.77% | -14.7% | |
| CRSP | Sell | CRISPR THERAPEUTICS AGput | $9,644,000 | -26.7% | 115,300 | -35.6% | 0.70% | -33.3% |
| INCY | New | INCYTE CORPput | $8,974,000 | – | 100,000 | +100.0% | 0.65% | – |
| ETNB | New | 89BIO INC | $8,730,000 | – | 340,236 | +100.0% | 0.63% | – |
| FGEN | Buy | FIBROGEN INCput | $8,301,000 | +156.0% | 201,900 | +152.4% | 0.60% | +132.9% |
| FGEN | FIBROGEN INCcall | $8,222,000 | +1.4% | 200,000 | 0.0% | 0.60% | -7.8% | |
| ARDX | Buy | ARDELYX INC | $8,036,000 | -16.6% | 1,530,436 | +9.9% | 0.58% | -24.1% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCput | $7,280,000 | – | 50,000 | +100.0% | 0.53% | – |
| GOSS | Sell | GOSSAMER BIO INC | $7,229,000 | -21.0% | 582,494 | -17.3% | 0.52% | -28.2% |
| DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $7,183,000 | – | 140,000 | +100.0% | 0.52% | – |
| SAGE | Sell | SAGE THERAPEUTICS INC | $7,099,000 | -15.1% | 116,151 | -42.3% | 0.51% | -22.8% |
| SBBP | Buy | STRONGBRIDGE BIOPHARMA PLC | $7,061,000 | -42.9% | 3,362,242 | +2.8% | 0.51% | -48.1% |
| IMAB | New | I MABsponsored ads | $7,054,000 | – | 150,000 | +100.0% | 0.51% | – |
| CHMA | Buy | CHIASMA INC | $7,008,000 | -8.9% | 1,629,633 | +14.0% | 0.51% | -17.2% |
| CYTK | New | CYTOKINETICS INCput | $6,927,000 | – | 320,000 | +100.0% | 0.50% | – |
| IMTX | New | IMMATICS N.V | $6,770,000 | – | 638,094 | +100.0% | 0.49% | – |
| KURA | Buy | KURA ONCOLOGY INCcall | $6,721,000 | +174.9% | 219,400 | +46.3% | 0.49% | +149.2% |
| BTAI | Buy | BIOXCEL THERAPEUTICS INCcall | $6,504,000 | -17.5% | 150,000 | +0.8% | 0.47% | -25.0% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INcall | $6,459,000 | – | 150,000 | +100.0% | 0.47% | – |
| ITCI | Sell | INTRA CELLULAR THERAPIES INCcall | $6,415,000 | -45.6% | 250,000 | -45.6% | 0.46% | -50.5% |
| MRTX | New | MIRATI THERAPEUTICS INC | $6,402,000 | – | 38,557 | +100.0% | 0.46% | – |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $6,183,000 | +3242.2% | 240,989 | +3246.1% | 0.45% | +2880.0% |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $6,028,000 | – | 100,000 | +100.0% | 0.44% | – |
| ARPO | New | AERPIO PHARMACEUTICALS INC | $5,914,000 | – | 3,942,460 | +100.0% | 0.43% | – |
| RPTX | New | REPARE THERAPEUTICS INC | $5,858,000 | – | 190,410 | +100.0% | 0.42% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCput | $5,592,000 | -57.2% | 57,400 | -31.4% | 0.40% | -61.0% |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $5,531,000 | – | 426,800 | +100.0% | 0.40% | – |
| CCXI | New | CHEMOCENTRYX INCcall | $5,480,000 | – | 100,000 | +100.0% | 0.40% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $5,342,000 | – | 153,048 | +100.0% | 0.39% | – |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $5,254,000 | +629.7% | 342,998 | +1113.1% | 0.38% | +566.7% |
| DCPH | DECIPHERA PHARMACEUTICALS INput | $5,131,000 | -14.1% | 100,000 | 0.0% | 0.37% | -21.9% | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $4,907,000 | +10340.4% | 724,680 | +14393.6% | 0.36% | +8775.0% |
| STRO | New | SUTRO BIOPHARMA INC | $4,904,000 | – | 488,000 | +100.0% | 0.36% | – |
| SAGE | Sell | SAGE THERAPEUTICS INCcall | $4,847,000 | -49.2% | 79,300 | -65.4% | 0.35% | -53.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $4,408,000 | +4264.4% | 756,236 | +4969.3% | 0.32% | +3887.5% |
| LYRA | New | LYRA THERAPEUTICS INC | $4,338,000 | – | 387,939 | +100.0% | 0.31% | – |
| HST | New | HOST HOTELS & RESORTS INCput | $4,317,000 | – | 400,000 | +100.0% | 0.31% | – |
| CHAQU | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $4,221,000 | +0.5% | 400,000 | 0.0% | 0.30% | -8.7% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INCcall | $4,155,000 | -44.5% | 403,400 | +12.5% | 0.30% | -49.5% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INCput | $4,126,000 | -57.4% | 100,000 | -50.0% | 0.30% | -61.2% |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $4,050,000 | +2.8% | 1,800,000 | +63.6% | 0.29% | -6.4% |
| AGEN | New | AGENUS INC | $3,800,000 | – | 950,000 | +100.0% | 0.28% | – |
| ARVN | Buy | ARVINAS INCcall | $3,771,000 | +6.0% | 159,700 | +50.5% | 0.27% | -3.5% |
| KDMN | Sell | KADMON HLDGS INC | $3,673,000 | -26.9% | 936,615 | -4.5% | 0.27% | -33.5% |
| ARYBU | New | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $3,501,000 | – | 318,206 | +100.0% | 0.25% | – |
| CARA | CARA THERAPEUTICS INC | $3,481,000 | -25.6% | 273,524 | 0.0% | 0.25% | -32.3% | |
| CMRX | New | CHIMERIX INC | $3,397,000 | – | 1,364,044 | +100.0% | 0.25% | – |
| KALA | New | KALA PHARMACEUTICALS INC | $3,387,000 | – | 451,531 | +100.0% | 0.24% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $3,350,000 | +2739.0% | 313,890 | +3150.1% | 0.24% | +2588.9% |
| ZGNX | Sell | ZOGENIX INC | $3,274,000 | -76.1% | 182,591 | -64.0% | 0.24% | -78.3% |
| ACET | New | ADICET BIO INC | $3,261,000 | – | 274,277 | +100.0% | 0.24% | – |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $3,184,000 | -33.2% | 63,011 | -37.0% | 0.23% | -39.3% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INCput | $3,036,000 | +53.4% | 294,800 | +211.0% | 0.22% | +40.1% |
| LSAC | New | LIFESCI ACQUISITION CORP | $2,999,000 | – | 241,762 | +100.0% | 0.22% | – |
| PAND | New | PANDION THERAPEUTICS INC | $2,978,000 | – | 260,000 | +100.0% | 0.22% | – |
| MYOV | New | MYOVANT SCIENCES LTDcall | $2,810,000 | – | 200,000 | +100.0% | 0.20% | – |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $2,809,000 | -41.7% | 23,654 | -44.4% | 0.20% | -47.1% |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $2,771,000 | – | 340,318 | +100.0% | 0.20% | – |
| MCRB | New | SERES THERAPEUTICS INC | $2,701,000 | – | 95,430 | +100.0% | 0.20% | – |
| AGTC | APPLIED GENETIC TECHNOLOGIES | $2,654,000 | -12.2% | 545,884 | 0.0% | 0.19% | -20.3% | |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $2,628,000 | – | 2,389,891 | +100.0% | 0.19% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $2,589,000 | -29.5% | 157,468 | 0.0% | 0.19% | -36.0% | |
| ITCI | New | INTRA CELLULAR THERAPIES INCput | $2,567,000 | – | 100,000 | +100.0% | 0.19% | – |
| HROW | New | HARROW HEALTH INC | $2,563,000 | – | 458,607 | +100.0% | 0.18% | – |
| MBIO | Buy | MUSTANG BIO INC | $2,541,000 | +124.1% | 806,475 | +126.2% | 0.18% | +104.4% |
| NKTR | NEKTAR THERAPEUTICScall | $2,488,000 | -28.4% | 150,000 | 0.0% | 0.18% | -34.8% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $2,470,000 | -33.9% | 223,173 | -25.2% | 0.18% | -39.9% |
| New | ACHIEVE LIFE SCIENCES INC | $2,379,000 | – | 284,151 | +100.0% | 0.17% | – | |
| CASI | Buy | CASI PHARMACEUTICALS INC | $2,356,000 | -9.4% | 1,539,910 | +48.1% | 0.17% | -17.4% |
| CLVS | Sell | CLOVIS ONCOLOGY INCcall | $2,332,000 | -27.6% | 400,000 | -16.1% | 0.17% | -34.0% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,310,000 | +3.6% | 56,008 | +21.7% | 0.17% | -5.6% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,173,000 | -66.1% | 40,281 | -61.6% | 0.16% | -69.2% |
| PSTX | New | POSEIDA THERAPEUTICS INC | $2,022,000 | – | 228,000 | +100.0% | 0.15% | – |
| CRTX | New | CORTEXYME INC | $2,000,000 | – | 40,000 | +100.0% | 0.14% | – |
| FATE | FATE THERAPEUTICS INCcall | $2,003,000 | +16.5% | 50,100 | 0.0% | 0.14% | +5.8% | |
| FATE | FATE THERAPEUTICS INCput | $2,003,000 | +16.5% | 50,100 | 0.0% | 0.14% | +5.8% | |
| NXTC | New | NEXTCURE INC | $1,760,000 | – | 200,000 | +100.0% | 0.13% | – |
| DMAC | New | DIAMEDICA THERAPEUTICS INC | $1,759,000 | – | 415,000 | +100.0% | 0.13% | – |
| OTIC | Sell | OTONOMY INC | $1,761,000 | -54.4% | 434,786 | -59.3% | 0.13% | -58.8% |
| VSTM | Sell | VERASTEM INC | $1,710,000 | -48.0% | 1,413,327 | -26.1% | 0.12% | -52.7% |
| APTX | Sell | APTINYX INC | $1,675,000 | -32.0% | 495,490 | -16.2% | 0.12% | -38.3% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,668,000 | -45.8% | 695,529 | -58.6% | 0.12% | -50.6% |
| AVRO | New | AVROBIO INC | $1,628,000 | – | 125,000 | +100.0% | 0.12% | – |
| ICAD | Sell | ICAD INC | $1,596,000 | -48.8% | 181,337 | -41.9% | 0.12% | -53.2% |
| SLDB | SOLID BIOSCIENCES INC | $1,600,000 | -30.7% | 788,008 | 0.0% | 0.12% | -37.0% | |
| ALT | Sell | ALTIMMUNE INC | $1,502,000 | -15.0% | 113,768 | -31.0% | 0.11% | -22.7% |
| AUPH | New | AURINIA PHARMACEUTICALS INCcall | $1,474,000 | – | 100,000 | +100.0% | 0.11% | – |
| IMMU | IMMUNOMEDICS INCcall | $1,369,000 | +139.8% | 16,100 | 0.0% | 0.10% | +120.0% | |
| CYTK | New | CYTOKINETICS INC | $1,190,000 | – | 55,000 | +100.0% | 0.09% | – |
| DCTH | DELCATH SYS INC | $1,092,000 | +13.3% | 94,000 | 0.0% | 0.08% | +2.6% | |
| GOSS | New | GOSSAMER BIO INCcall | $1,009,000 | – | 81,300 | +100.0% | 0.07% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEWcall | $946,000 | -73.5% | 63,800 | -76.8% | 0.07% | -76.1% |
| BIIB | Buy | BIOGEN INC | $852,000 | +300.0% | 3,000 | +277.4% | 0.06% | +264.7% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $820,000 | +53.8% | 177,684 | -5.9% | 0.06% | +40.5% |
| PCVX | Sell | VAXCYTE INC | $796,000 | -82.0% | 16,110 | -88.5% | 0.06% | -83.5% |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $784,000 | – | 50,000 | +100.0% | 0.06% | – |
| ANAB | Buy | ANAPTYSBIO INC | $738,000 | +623.5% | 50,000 | +991.5% | 0.05% | +562.5% |
| CARA | Buy | CARA THERAPEUTICS INCcall | $738,000 | +120.3% | 58,000 | +195.9% | 0.05% | +96.3% |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $688,000 | – | 1,196,308 | +100.0% | 0.05% | – |
| IFRX | Sell | INFLARX NV | $637,000 | -9.0% | 149,750 | -1.9% | 0.05% | -17.9% |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $596,000 | -17.6% | 164,730 | 0.0% | 0.04% | -25.9% | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $565,000 | +718.8% | 18,726 | +780.8% | 0.04% | +720.0% |
| PBYI | PUMA BIOTECHNOLOGY INC | $554,000 | -3.3% | 54,901 | 0.0% | 0.04% | -13.0% | |
| AL | New | AIR LEASE CORPput | $518,000 | – | 17,600 | +100.0% | 0.04% | – |
| RAPT | New | RAPT THERAPEUTICS INCput | $503,000 | – | 15,600 | +100.0% | 0.04% | – |
| ADMA | Sell | ADMA BIOLOGICS INC | $478,000 | -56.9% | 200,000 | -47.2% | 0.04% | -60.2% |
| CERC | Sell | CERECOR INC | $460,000 | -56.1% | 202,865 | -49.6% | 0.03% | -60.2% |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGScall | $397,000 | -95.3% | 220,100 | -78.0% | 0.03% | -95.7% |
| ARNA | ARENA PHARMACEUTICALS INC | $373,000 | +18.4% | 5,000 | 0.0% | 0.03% | +8.0% | |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $360,000 | – | 115,000 | +100.0% | 0.03% | – |
| EPZM | New | EPIZYME INC | $347,000 | – | 29,080 | +100.0% | 0.02% | – |
| NVAX | New | NOVAVAX INC | $286,000 | – | 2,636 | +100.0% | 0.02% | – |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $275,000 | -93.0% | 54,694 | -88.8% | 0.02% | -93.6% |
| BXRX | BAUDAX BIO INC | $277,000 | -33.3% | 100,000 | 0.0% | 0.02% | -39.4% | |
| MLND | MILLENDO THERAPEUTICS INC | $220,000 | -7.6% | 135,193 | 0.0% | 0.02% | -15.8% | |
| BLU | New | BELLUS HEALTH INC NEW | $227,000 | – | 100,000 | +100.0% | 0.02% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $205,000 | – | 2,641 | +100.0% | 0.02% | – |
| ARGX | Sell | ARGENX SEput | $209,000 | -99.3% | 800 | -99.4% | 0.02% | -99.3% |
| TCDA | Sell | TRICIDA INC | $210,000 | -95.7% | 23,193 | -86.9% | 0.02% | -96.1% |
| KURA | Sell | KURA ONCOLOGY INC | $189,000 | -97.5% | 6,203 | -98.7% | 0.01% | -97.7% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INCcall | $179,000 | -72.4% | 10,000 | -60.8% | 0.01% | -75.0% |
| DRNA | DICERNA PHARMACEUTICALS INCput | $179,000 | -29.5% | 10,000 | 0.0% | 0.01% | -35.0% | |
| IVA | New | INVENTIVA SAads | $177,000 | – | 15,000 | +100.0% | 0.01% | – |
| RAPT | New | RAPT THERAPEUTICS INCcall | $170,000 | – | 5,300 | +100.0% | 0.01% | – |
| CRTX | New | CORTEXYME INCput | $150,000 | – | 3,000 | +100.0% | 0.01% | – |
| CRTX | New | CORTEXYME INCcall | $150,000 | – | 3,000 | +100.0% | 0.01% | – |
| MESO | New | MESOBLAST LTDput | $145,000 | – | 7,800 | +100.0% | 0.01% | – |
| BTAI | Sell | BIOXCEL THERAPEUTICS INC | $117,000 | -99.2% | 2,714 | -99.0% | 0.01% | -99.3% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS INput | $117,000 | -98.2% | 2,100 | -97.9% | 0.01% | -98.4% |
| OVID | New | OVID THERAPEUTICS INCcall | $92,000 | – | 16,000 | +100.0% | 0.01% | – |
| MITO | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $50,000 | -27.5% | 37,597 | 0.0% | 0.00% | -20.0% | |
| DTIL | PRECISION BIOSCIENCES INC | $55,000 | -24.7% | 8,812 | 0.0% | 0.00% | -33.3% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $41,000 | -10.9% | 4,739 | 0.0% | 0.00% | -25.0% | |
| New | APTOSE BIOSCIENCES INC | $23,000 | – | 3,904 | +100.0% | 0.00% | – | |
| ALEC | New | ALECTOR INC | $3,000 | – | 321 | +100.0% | 0.00% | – |
| CCXI | New | CHEMOCENTRYX INC | $1,000 | – | 37 | +100.0% | 0.00% | – |
| BCTG | New | BCTG ACQUISITION CORP | $2,000 | – | 250 | +100.0% | 0.00% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -1,159 | -100.0% | -0.00% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -111,445 | -100.0% | -0.00% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -8,674 | -100.0% | -0.01% | – |
| INSM | Exit | INSMED INC | $0 | – | -2,919 | -100.0% | -0.01% | – |
| AEZS | Exit | AETERNA ZENTARIS INC | $0 | – | -117,443 | -100.0% | -0.01% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -1,154 | -100.0% | -0.01% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -2,313 | -100.0% | -0.01% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -5,000 | -100.0% | -0.02% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -16,000 | -100.0% | -0.02% | – |
| GNFT | Exit | GENFIT S Aads | $0 | – | -64,027 | -100.0% | -0.03% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -1,750 | -100.0% | -0.03% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -3,700 | -100.0% | -0.03% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -22,840 | -100.0% | -0.04% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -6,218 | -100.0% | -0.04% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -82,573 | -100.0% | -0.04% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -25,999 | -100.0% | -0.04% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -336,801 | -100.0% | -0.06% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -31,500 | -100.0% | -0.08% | – |
| OTIC | Exit | OTONOMY INCcall | $0 | – | -300,000 | -100.0% | -0.09% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INCput | $0 | – | -346,300 | -100.0% | -0.10% | – |
| CLLS | Exit | CELLECTIS S Aspon ads | $0 | – | -73,067 | -100.0% | -0.10% | – |
| ACHV | Exit | ACHIEVE LIFE SCIENCE INC | $0 | – | -3,658,537 | -100.0% | -0.12% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -18,300 | -100.0% | -0.12% | – |
| MCRB | Exit | SERES THERAPEUTICS INCput | $0 | – | -352,300 | -100.0% | -0.13% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INput | $0 | – | -35,500 | -100.0% | -0.14% | – |
| MRNA | Exit | MODERNA INCcall | $0 | – | -30,000 | -100.0% | -0.15% | – |
| Exit | HORIZON THERAPEUTICS PUB LTD | $0 | – | -37,641 | -100.0% | -0.17% | – | |
| BLUE | Exit | BLUEBIRD BIO INCcall | $0 | – | -35,000 | -100.0% | -0.17% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -647,400 | -100.0% | -0.17% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INCcall | $0 | – | -641,600 | -100.0% | -0.18% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INCcall | $0 | – | -1,050,000 | -100.0% | -0.19% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INCput | $0 | – | -692,500 | -100.0% | -0.19% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INCput | $0 | – | -1,178,800 | -100.0% | -0.21% | – |
| ALBO | Exit | ALBIREO PHARMA INCcall | $0 | – | -100,500 | -100.0% | -0.21% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -42,536 | -100.0% | -0.24% | – |
| TORC | Exit | RESTORBIO INC | $0 | – | -1,452,551 | -100.0% | -0.25% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INCcall | $0 | – | -961,400 | -100.0% | -0.26% | – |
| XLRN | Exit | ACCELERON PHARMA INCput | $0 | – | -34,500 | -100.0% | -0.26% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -50,000 | -100.0% | -0.29% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -37,700 | -100.0% | -0.37% | – |
| ARVN | Exit | ARVINAS INCput | $0 | – | -154,000 | -100.0% | -0.41% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -327,771 | -100.0% | -0.42% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -1,529,830 | -100.0% | -0.42% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL INcall | $0 | – | -73,500 | -100.0% | -0.46% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -150,000 | -100.0% | -0.57% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -3,369,976 | -100.0% | -0.62% | – |
| XLE | Exit | SELECT SECTOR SPDR TRput | $0 | – | -243,100 | -100.0% | -0.73% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -328,824 | -100.0% | -0.75% | – |
| CVM | Exit | CEL SCI CORPput | $0 | – | -637,700 | -100.0% | -0.76% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORPcall | $0 | – | -128,400 | -100.0% | -0.80% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGSput | $0 | – | -1,350,000 | -100.0% | -0.90% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -439,300 | -100.0% | -0.94% | – |
| Exit | HORIZON THERAPEUTICS PUB LTDcall | $0 | – | -246,500 | -100.0% | -1.09% | – | |
| Exit | NOVAVAX INCput | $0 | – | -164,300 | -100.0% | -1.09% | – | |
| XLF | Exit | SELECT SECTOR SPDR TRput | $0 | – | -600,000 | -100.0% | -1.10% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS INcall | $0 | – | -230,000 | -100.0% | -1.16% | – |
| OHI | Exit | OMEGA HEALTHCARE INVS INCput | $0 | – | -500,000 | -100.0% | -1.18% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -201,662 | -100.0% | -1.25% | – |
| MYOK | Exit | MYOKARDIA INCput | $0 | – | -180,600 | -100.0% | -1.39% | – |
| XLRN | Exit | ACCELERON PHARMA INCcall | $0 | – | -187,700 | -100.0% | -1.42% | – |
| ACC | Exit | AMERICAN CAMPUS CMNTYS INCput | $0 | – | -550,000 | -100.0% | -1.53% | – |
| VNQ | Exit | VANGUARD INDEX FDSput | $0 | – | -250,000 | -100.0% | -1.56% | – |
| FXI | Exit | ISHARES TRput | $0 | – | -600,000 | -100.0% | -1.90% | – |
| CCXI | Exit | CHEMOCENTRYX INCput | $0 | – | -500,000 | -100.0% | -2.29% | – |
| QQQ | Exit | INVESCO QQQ TRcall | $0 | – | -125,000 | -100.0% | -2.46% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORPput | $0 | – | -400,000 | -100.0% | -2.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.